Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 11, 2008 - Issue 2
30
Views
8
CrossRef citations to date
0
Altmetric
Research article

Functional relationships between serum total cholesterol levels, executive control, and sustained attention

, , &
Pages 84-94 | Published online: 19 Jul 2013

References

  • Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr 2004; 24: 401–431.
  • Prentice AM, Jebb SA. Fast foods, energy density, and obesity: a possible mechanistic link. Obes Rev 2003; 4: 187–194.
  • Astrup A. Super-sized and diabetic by frequent fast-food consumption? Lancet 2005; 365: 4–5.
  • Greenwood CE, Winocur G. Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 1990; 53: 74–87.
  • Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav Neurosci 1996; 110: 451–459.
  • Winocur G, Greenwood CE. High-fat diets impair conditional discrimination learning in rats. Psychobiology 1993; 21: 286–292.
  • Winocur G, Greenwood CE. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999; 101: 153–161.
  • Benton D. Dietary fat and cognitive functioning. In: Hillbrand M, Spitz RT. (eds) Lipids, Health, and Behavior. Washington, DC: American Psychological Association, 1997; 227–243.
  • Kaplan JR, Greenwood CE. Dietary saturated fatty acids and brain function. Neurochem Res 1998; 23: 615–626.
  • Dye L, Lluch A, Blundell JE. Macronutrients and mental performance. Nutrition 2000; 16: 1021–1034.
  • Molteni R, Barnard RJ, Ying Z, Roberts CK, Gomez-Pinilla F. A high- fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002; 112: 803–814.
  • Wu A, Molteni R, Ying Z, Gomez-Pinilla F. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 2003; 119: 365–375.
  • Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001; 12: 105–112.
  • Rogers PJ. A healthy body, a healthy mind: long term impact of diet on mood and cognitive function. Proc Nutr Soc 2001; 60: 135–143.
  • Michikawa M. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer’s disease? JNeurosci Res 2003; 72: 141–146.
  • Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000; 108: 538–546.
  • Wardle J, Rogers P, Judd P, et al. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med 2000; 108: 547–553.
  • Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 2003; 74: 1530–1535.
  • Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30–59 years of age (NHANES III). Neuroepidemiology 2005; 24: 42–50.
  • Benton D. Do low cholesterol levels slow mental processing? Psychosom Med 1995; 57: 50–53.
  • Muldoon MF, Ryan CM, Matthews KA, Manuck SB. Serum cholesterol and intellectual performance. Psychosom Med 1997; 59: 382–387.
  • Elias PK, Elias MF, D’Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med 2005; 67: 24–30.
  • Zhang J, Muldoon MF, McKeown RE. Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 2004; 80: 291–298.
  • Puttonen S, Elovainio M, Kivimäki M, Lehtimäki T, Keltikangas- Järvinen L. The combined effects of apolipoprotein E polymorphism and low-density lipoprotein cholesterol on cognitive performance in young adults. Neuropsychobiology 2003; 48: 35–40.
  • Reitan RM, Shipley RE. The relationship of serum cholesterol changes to psychological abilities. J Gerontol 1963; 18: 350–356.
  • Kaplan JR, Manuck SB, Shively C. The effects of fat and cholesterol on social behavior in monkeys. Psychosom Med 1991; 53: 634–642.
  • Kaplan JR, Manuck SB, Fontenot MB, Muldoon MF, Shively CA, Mann JJ. The cholesterol-serotonin hypothesis: interrelationships among dietary lipids, central serotonergic activity, and social behavior in monkeys. In: Hillbrand M, Spitz RT. (eds) Lipids, Health, and Behavior. Washington, DC: American Psychological Association, 1997;139–165.
  • Mason RP, Herbette LG, Silverman DI. Can altering serum cholesterol affect neurologic function? J Mol Cell Cardiol 1991; 23: 1339–1342.
  • Pozzi F, Troisi A, Cerilli M, et al. Serum cholesterol and impulsivity in a large sample of healthy young men. Psychiatry Res 2003; 120: 239–245.
  • Kaplan JR, Shively CA, Fontenot MB, et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosom Med 1994; 56: 479–484.
  • Arnsten AFT, Goldman-Rakic PS. Noise stress impairs prefrontal cortical cognitive function in monkeys. Arch Gen Psychiatry 1998; 55: 362–368.
  • Arnsten AFT. Development of the cerebral cortex: XIV. Stress impairs prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 1999; 38: 220–222.
  • Arnsten AFT. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog Brain Res 2000; 126: 183–192.
  • Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AFT. A role for norepinephrine in stress-induced cognitive deficits: alpha-1- adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 1999; 46: 1266–1274.
  • Sapolsky RM. Why stress is bad for your brain. Science 1996; 273: 749–750.
  • Wang M. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome. Nutr Metab [serial online] 2005; 2: Article 3. <http://www.nutritionandmetabolism.com/content/2/1/3 > [Accessed 20 July 2005].
  • Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001; 2: 73–86.
  • Bjorntorp P, Rosmond R. The metabolic syndrome - A neuroendocrine disorder? Br J Nutr 2000; 83: S49–S57.
  • Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue related causes. Int J Obes 2000; 24: S50–S55.
  • Oliver G, Wardle J, Gibson EL. Stress and food choice: a laboratory study. Psychosom Med 2000; 62: 853–865.
  • Cholestech Corporation. The accuracy and reproducibility of a rapid, fingerstick method for measuring a complete lipid profile is comparable to a reference laboratory method (Technical Brief MKT12269 rev. B). Hayward, CA: Cholestech Corporation, 2003. <http://www.cholestech.com/support/techsupp/accuracy.asp> [accessed 22 July 2005].
  • Ose L, Aass B, Christophersen B. [A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids]. Tidsskr Nor Laegeforen 1995; 115: 3487–3489.
  • Issa JS, Strunz C, Giannini SD, Forti N, Diament J. [Precision and accuracy of blood lipid analyses by a portable device (Cholestech- LDX)]. Arq Bras Cardiol 1996; 66: 339–342.
  • Volles DF, McKenney JM, Miller WG, Ruffen D, Zhang D. Analytic and clinical performance of two compact cholesterol-testing devices. Pharmacotherapy 1998; 18: 184–192.
  • Santee J. Accuracy and precision of the Cholestech LDX system in monitoring blood lipid levels. Am J Health Syst Pharm 2002; 59: 1774–1779.
  • Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA. Inaccuracy of lipid measurements with the portable Cholestech LDX analyzer in patients with hypercholesterolemia. Clin Chem2002; 48: 284–290.
  • Rubin DA, McMurray RG, Harrell JS, Carlson BW, Bangdiwala S. Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification. Int J Sport Nutr Exerc Metab 2003; 13: 358–363.
  • Panz VR, Raal FJ, Paiker J, Immelman R, Miles H. Performance of the CardioChek™ PA and Cholestech LDX® point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J South Afr 2005; 16: 112–115.
  • Shemesh T, Rowley KG, Shephard M, Piers LS, O’Dea K. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta 2006; 367: 69–76.
  • Moos RH, Moos BS. Life Stressors and Social Resources Inventory - Adult Form Professional Manual. Lutz, FL: Psychological Assessment Resources, 1994.
  • Moos RH, Fenn CB, Billings AG. Life stressors and social resources: an integrated assessment approach. Soc Sci Med 1988; 27: 999–1002.
  • Shallice T. Specific impairments in planning. Philos Trans R Soc Lond B Biol Sci 1982; 298: 199–209.
  • Culbertson WC, Zillmer EA. The Tower of LondonDX: a standardized approach to assessing executive functioning in children. Arch Clin Neuropsychol 1998; 13: 285–301.
  • Culbertson WC, Zillmer EA. Tower of London Drexel University, 2nd edn (TOLDX) technical manual. North Tonawanda, NY: Multi-Health Systems, 2005.
  • Lewis RF. Digit Vigilance Test Professional User’s Guide. Lutz, FL: Psychological Assessment Resources, 1995.
  • Kelland DZ, Lewis RF. The Digit Vigilance Test: reliability, validity, and sensitivity to diazepam. Arch Clin Neuropsychol 1996; 11: 339–344.
  • Canfield RL, Gendle MH, Cory-Slechta DA. Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol 2004; 26: 513–540.
  • Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125–137.
  • Posner MI, Peterson SE. The attention system of the human brain. Annu Rev Neurosci 1990; 13: 254–2.
  • Goel V, Grafman J. Are the frontal lobes implicated in ‘planning’ functions? Interpreting data from the Tower of Hanoi. Neuropsychologia 1995; 33: 623–642.
  • Baker SC, Rogers RD, Owen AM, et al. Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia 1996;34: 515–526.
  • Granon S, Hardouin J, Courtiere A, Poucet B. Evidence for the involvement of the rat prefrontal cortex in sustained attention. Q J Exp Psychol 1998; 51B: 219–233.
  • Rowe JB, Owen AM, Johnsrude IS, Passingham RE. Imaging the mental components of a planning task. Neuropsychologia 2001; 39: 315–327.
  • Sarter M, Givens B, Bruno JP. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Rev 2001; 35: 146–160.
  • Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham Heart Study. Int J Obes 2003; 27: 260–268.
  • Cournot M, Marquié J-C, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006; 67: 1208–1214.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
  • Kuller LH. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 2004; 15: 109–113.
  • Forouhi NG, Sattar N. CVD risk factors and ethnicity - A homogeneous relationship?. Atheroscler Suppl 2006; 7: 11–19.
  • Lloyd HM, Green MW, Rogers PJ. Mood and cognitive performance effects of isocaloric lunches differing in fat and carbohydrate content. Physiol Behav 1994; 56: 51–57.
  • Dubois C, Armand M, Mekki N, et al. Effects on increasing amounts of dietary cholesterol on postprandial lipemia and lipoproteins in human subjects. J Lipid Res 1994; 35: 1993–2007.
  • Dubois C, Beaumier G, Juhel C, et al. Effects of graded amounts (0–50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1998; 67: 31–38.
  • Lairon, D. Nutritional and metabolic aspects of postprandial lipemia. Reprod Nutr Dev 1996; 36: 345–355.
  • Dubois C, Armand M, Azais-Braesco V, et al. Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1994; 60: 374–382.
  • Dubois C, Armand M, Ferezou J, et al. Postprandial appearance of dietary deuterated cholesterol in the cylomicron fraction and whole plasma in healthy subjects. Am J Clin Nutr 1996; 64: 47–52.
  • Bergeron N, Havel RJ. Assessment of postprandial lipemia: nutritional influences. Curr Opin Lipidol 1997; 8: 43–52.
  • Lloyd HM, Rogers PJ, Hedderley DI, Walker AF. Acute effects on mood and cognitive performance of breakfasts differing in fat and carbohydrate content. Appetite 1996; 27: 151–164.
  • Vance JE, Hayashi H, Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 2005; 16: 193–212.
  • Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415–1428.
  • Flordellis CS, Ilias I, Papavassiliou AG. New therapeutic options for the metabolic syndrome: what’s next? Trends Endocrinol Metab 2005; 16: 254–260.
  • Herz J, Bock HH. Lipoprotein receptors in the nervous system. Annu Rev Biochem 2002; 71: 405–434.
  • Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004; 24: 806–815.
  • Dehouck B, Fenart L, Dehouck M-P, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138: 877–889.
  • Fagan AM, Younkin LH, Morris JC, et al. Differences in the Aß40/Aß42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 2000; 48: 201–210.
  • Fassbender K, Stroick M, Bertsch T, et al. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 2002; 59: 1257–1258.
  • Qiu S, Korwek KM, Weeber EJ. A fresh look at an ancient receptor family: Emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol Learn Mem 2006; 85: 16–29.
  • Kessler AR, Kessler B, Yehuda S. Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and a plant oil mixture. Biochem Pharmacol 1985; 34: 1120–1121.
  • Kessler AR, Kessler B, Yehuda S. In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indications for interactions between hippocampal-cortical cholesterol and learning. Life Sci 1986; 38: 1185–1192.
  • Fuster JM. The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. Philadelphia, PA: Lippincott- Raven, 1997.
  • Fuster JM. Executive frontal functions. Exp Brain Res 2000; 133: 66–70.
  • Fuster JM, Bodner M, Kroger JK. Cross-modal and cross-temporal association in neurons of frontal cortex. Nature 2000; 405: 347–351.
  • Kimberg DY, D’Esposito MD, Farah MJ. Cognitive functions in the prefrontal cortex-working memory and executive control. Curr Dir Psychol Sci 1998; 6: 185–192.
  • Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167–202.
  • Constantinidis C, Williams GV, Goldman-Rakic PS. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat Neurosci 2002; 5: 175–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.